Non Small Cell Lung Cancer Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- Decitabine (DAC)
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022A
Recruiting
- Non-small Cell Lung Cancer
- Birmingham, Alabama
- +45 more
2022-04-06
Apr 6, 2022M
Recruiting
- Non-Small Cell Lung Cancer
- Pembrolizumab SC
- +6 more
- Jonesboro, Arkansas
- +103 more
2022-04-07
Apr 7, 2022N
Recruiting
- Endocrine/Neuroendocrine
- +4 more
- Fludarabine
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022L
Recruiting
- Non-Small Cell Lung Cancer
- Selpercatinib
- +4 more
- Berazategui, Buenos Aires, Argentina
- +206 more
2022-04-06
Apr 6, 2022S
Active, not recruiting
- Non-small Cell Lung Cancer
- sintilimab
- +3 more
- Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
2022-04-06
Apr 6, 2022C
Active, not recruiting
- Non-Small Cell Lung Cancer
- Baltimore, Maryland
- +5 more
2022-04-07
Apr 7, 2022H
Recruiting
- Non-Small Cell Lung Cancer
- Alectinib
- +9 more
- La Jolla, California
- +181 more
2022-04-07
Apr 7, 2022N
Recruiting
- Endocrine Tumors
- +5 more
- Cyclophosphamide
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022M
Active, not recruiting
- Non-small Cell Lung Cancer
- ALT-803
- Nivolumab
- Weston, Florida
- +3 more
2022-03-30
Mar 30, 2022T
Not yet recruiting
- Non-Small Cell Lung Cancer
- Observation
- (no location specified)
2022-04-07
Apr 7, 2022M
Recruiting
- Non-Small Cell Lung Cancer
- Stereotactic Body Radiotherapy (SBRT)
- +2 more
- Birmingham, Alabama
- +169 more
2022-04-07
Apr 7, 2022D
Active, not recruiting
- Non-small Cell Lung Cancer
- Phoenix, Arizona
- +81 more
2022-04-07
Apr 7, 2022L
Recruiting
- Non-Small Cell Lung Cancer
- +3 more
- Scottsdale, Arizona
- +84 more
2022-04-06
Apr 6, 2022L
Recruiting
- Non-Small Cell Lung Cancer
- Chemoradiotherapy
- Chemoradiotherapy with Integrated Boost Dose
- London, Ontario, Canada
- +6 more
2022-04-07
Apr 7, 2022N
Recruiting
- Multiple Myeloma
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022N
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022N
Enrolling by invitation
- Melanoma
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022E
A
Recruiting
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Durvalumab
- +3 more
- Tucson, Arizona
- +18 more
2022-04-06
Apr 6, 2022W
Not yet recruiting
- Non Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Atlanta, Georgia
- +6 more
2022-03-29
Mar 29, 2022B
Recruiting
- Neoplasm Metastasis
- Non-Small Cell Lung Cancer
- BI 1810631
- Dallas, Texas
- +4 more
2022-04-06
Apr 6, 2022C
Terminated
- Non-small Cell Lung Cancer
- Shanghai, Shanghai, ChinaNo. 241 Huaihai West Road, Xuhui District, Shanghai
2022-03-29
Mar 29, 2022N
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
- Grand Rapids, Michigan
- +2 more
2022-04-05
Apr 5, 2022M
Recruiting
- Non-Small Cell Lung Cancer
- Sotorasib and Tarloxotinib
- Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
2022-03-28
Mar 28, 2022